OPTIMIZATION OF DOXORUBICIN-LOADED Γ-POLYGLUTAMIC ACID-CHITOSAN NANOPARTICLES

ISSN: 1875-5704 (Online)
ISSN: 1567-2018 (Print)


Volume 12, 6 Issues, 2015


Download PDF Flyer




Current Drug Delivery

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Istvan Toth
School of Pharmacy,University of Queensland
Brisbane, 4072
Australia


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 1.478

OPTIMIZATION OF DOXORUBICIN-LOADED Γ-POLYGLUTAMIC ACID-CHITOSAN NANOPARTICLES

Author(s): Frank Hellmers, Rainer Krull and Argyrios Margaritis

Affiliation: Institute of Biochemical Engineering, Technische UniversitätBraunschweig, Gaußstraße 17, 38106, Braunschweig, Germany.

Abstract

The purpose of this research was to characterize and optimize the production of chitosan (CS) and γ-polyglutamic acid (γ-PGA) nanoparticles generated through the polyelectrolyte complexation process for application as doxorubicin (DOX) delivery system. The characterization of thedrug carrierCS:γ-PGA nanoparticles revealed that polymer concentration and mass ratio, as well as solution pH are parameters that significantly influence the complex formation process. Increasing the CS and γ-PGA concentrations was shown to result in an increased particle size. CS:γ-PGA nanoparticles with particles sizes ranging from 215 to 693 nm at pH 6 were produced. Microscopy examination of the CS:γ-PGA nanoparticles showed a round to oval shape and narrow size distribution. A statistical method of experimental design, known as Response Surface Modeling, was applied in order to obtain the optimal production conditions for further medical application. The goal was to produce nanoparticles with the smallest size at the highest pH possible, optimization yielded DOX-loaded nanoparticles of 197.6 nm in size produced with initial concentrations of 0.25 mg/mL CS and 0.46 mg/mL DOX:γ-PGA, and a pH of 6.5.


Purchase Online Order Reprints Order Eprints Rights and Permissions

  
  



Article Details

Volume: 10
First Page: 1
Page Count: 1
DOI: 10.2174/15672018113109990048
Advertisement
Orphan Drugs and Rare Diseases Conference

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2015 Bentham Science